efficacy of semaglutide and tirzepatide in reducing liver fat Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? Semaglutide vs Tirzepatide: Which GLP-1

Neurological recovery: B12-dependent myelin sheath maintenance is relevant not only in neurological FIP presentations but in any cat whose systemic illness has produced peripheral neurological effects including the generalised weakness and proprioceptive deficits seen in severe wet FIP cases

Diabetologia 59 , 560570 (2016)

As of April 2026, semaglutide remains on the shortage list, but Novo Nordisk has reported to the FDA that manufacturing capacity will meet projected U.S

administered 15 min before d-allulose injection

Side effects or tolerability issues Many clients have side effects when starting GLP-1 RA medications, these include nausea, vomiting, constipation, and other gastrointestinal discomfort.5 For some, the side effects can interfere with their effectiveness particularly when the side effects are severe enough for clients to stop taking the medication or miss doses

Stopping or lowering the dose usually resolves them quickly